Neovascularization Inhibitors Derived From HGF and Methods Involving the Same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Aug 5, 2008
filing date -
Apr 28, 1998
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
in HGF (hepatocyte growth factor); or (b) a polypeptide having an amino acid sequence derived from the amino acid sequence as defined in (a) by deletion, substitution or addition of one or several amino acids and having an antagonism to the effect of HGF via c-Met-HGF receptor.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully